Trial Profile
Phase Ia trial of oral amphotericin B as a potential therapy for life-threatening fungal and parasitic infections
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 30 Nov 2015
Price :
$35
*
At a glance
- Drugs Amphotericin B (Primary)
- Indications Mycoses; Parasitic infections
- Focus Adverse reactions; First in man
- Sponsors iCo Therapeutics
- 24 Nov 2015 According to an iCo Therapeutics media release, data from this trial is expected to be available in 2017.
- 04 Dec 2014 New trial record